Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Assets Average (2017 - 2025)

Historic Assets Average for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $198.9 million.

  • Puma Biotechnology's Assets Average fell 656.41% to $198.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.9 million, marking a year-over-year decrease of 656.41%. This contributed to the annual value of $221.9 million for FY2024, which is 192.8% down from last year.
  • As of Q3 2025, Puma Biotechnology's Assets Average stood at $198.9 million, which was down 656.41% from $195.5 million recorded in Q2 2025.
  • Puma Biotechnology's Assets Average's 5-year high stood at $259.3 million during Q2 2021, with a 5-year trough of $195.5 million in Q2 2025.
  • Its 5-year average for Assets Average is $215.0 million, with a median of $210.4 million in 2022.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 921.85% in 2021, then tumbled by 2396.98% in 2022.
  • Over the past 5 years, Puma Biotechnology's Assets Average (Quarter) stood at $226.4 million in 2021, then fell by 7.08% to $210.4 million in 2022, then increased by 3.16% to $217.1 million in 2023, then fell by 0.02% to $217.0 million in 2024, then decreased by 8.36% to $198.9 million in 2025.
  • Its Assets Average stands at $198.9 million for Q3 2025, versus $195.5 million for Q2 2025 and $204.8 million for Q1 2025.